Login

Stefan Poz on Moonfare's Mission and the Impact of ELTIF 2.0 00:10:00

Share On Facebook Share On Twitter

Dr. Steffen Pauls, CEO and Founder at Moonfare. Former Managing Director at KKR

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
PYX Resources' Export License and Its Role in Strengthening EBITDA | Oliver Hasler, CEO , PYX Resources Ltd.
00:10:00
Unveiling the Model H: Tesla's Hydrogen-Powered Revolution|Elon Musk,CEO,Tesla
00:10:00
Bigtincan with Proactive at ASX Small and Mid Cap Conference | David Keane, CEO, Bigtincan Holdings Ltd (ASX: BTH)
00:10:00
Interview with Peter Van Alfen on Nouveau Minerals' Quebec Exploration Projects at PDAC 2023.
00:10:00
Provides them with access to high-quality investment opportunities|Andrew Gershfeld,General Partner,Flint Capital
00:10:00
Revolutionizing Agriculture: Biofuel Circle's Impact on Sustainable Farming and Stubble Burning|Suhas Baxi,CEO,BiofuelCircle
00:10:00
supports founders with early-stage and seed VC funding, investing in their professional|Tony Kulesa,Principal,Pillar VC
00:10:00
Green Energy Strategy Unveiled: Ignito's Group Aims for 100% Renewable Power in Europe by 2050| Darius Maikštenas, CEO, Ignitis Grupe AB.
00:10:00
Develop disease modifying therapies to stop or reverse the progression of neurodegenerative diseases|ANTTI VUOLANTO,Chief Executive Officer,Herantis Pharma Oyj
00:10:00
Skyfii Ltd CEO Wayne Arthur tells Proactive about securing several new contract wins in the global airport sector.
00:10:00
Appian CEO Delivering ‘Mission-Critical’ Software | Matt Calkins, CEO, Appian CorpAPPN:NMQ
00:10:00
Covenant Logistics Group on Riskonnect | , , Covenant Logistics Group IncCVLG:NSQ

© 2026 Nehu